Arcus Biosciences COO Jennifer Jarrett to Resign Effective March 30, 2024
Published on · Source: investing.com
AI Summary
Summarized by AI from the source belowJennifer Jarrett, the Chief Operating Officer of Arcus Biosciences, announced her resignation, effective March 30, 2024. This development is notable as it could impact the company's operational strategy and direction. It remains to be seen how this change will influence investor sentiment and stock performance in the upcoming months. Arcus Biosciences has not provided specific details regarding interim leadership or the succession plan.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Related News
Earnings
Stanley Black & Decker (SWK) Achieves 64% Return After Fair Value Call
Sep 20
Earnings
Hy-Tech Engineers (HYE) Q1 FY27 Results Published Per SEBI Norms
Sep 20
Earnings
IBM (NYSE:IBM) Stock Falls 22% Year-to-Date, Revenue Slows
Sep 19
Earnings
Berkshire Hathaway Energy Revenue Reaches $11.2 Billion in 2026
Sep 19